Publications

The role of molecular pathology in the diagnosis, prognosis, and management of childhood tumors [HU]. Hófer et al.; Orvosi Hetilap, 2025, IF: 0.9, JCI: Q3, co-author

Comment on: A Comparative Analysis of Clinical Utility of Cell-Free DNA and Bone Marrow-Based Minimal Residual Disease Assessment in B-Cell Precursor ALL. Alpár D, Bedics G, Kiss R, Egyed B; Pediatric Blood & Cancer, 2025, IF: 2.9, JCI: Q2, co-author [Letter]

The significance of NTRK inhibition in pediatric neurological diseases [HU]. Brückner E, Kiss R et al.; Gyermekorvos Továbbképzés, 2025, co-author

Pediatric thyroid-like follicular renal cell carcinoma — a post-neuroblastoma case with comprehensive genomic profiling data. Kiss et al.; Virchows Archive, 2024, IF: 3.1, JCI: Q1, first author

Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax. Kotmayer et al.; International Journal of Molecular Sciences, 2023, IF: 4.9, JCI: Q1, co-author

Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax. Gángó et al.; Pathology, 2022, IF: 2.968, JCI: Q2, co-author

Significance of molecular genetic testing in chronic myeloid leukemia [HU]. Kiss et al.; Orvosképzés, 2021, corresponding author

The significance of intestinal microbiome in the development, screening and treatment of cancer [HU]. Tóth et al.; Orvosképzés, 2021, corresponding author

Screening and monitoring of the BTKC481S mutation in a real-world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy. Bödör et al.; British Journal of Haematology, 2021, IF: 3.9, JCI: Q1, co-author

BCR activated CLL B cells use both CR3 and CR4 for adhesion to complement opsonized targets. Nagy-Baló Z, Kiss R et al.; PLOS ONE, 2021, IF: 2.9, JCI: Q2, co-author

Retrospective analysis of CML patients treated at Hungarian centers between 2003–2019 [HU]. Weisinger J, Tárkányi I, Kiss R et al.; Orvosi Hetilap, 2021, IF: 0.9, JCI: Q3, co-author

Activated Human Memory B Lymphocytes Use CR4 (CD11c/CD18) for Adhesion, Migration, and Proliferation. Nagy-Baló et al.; Frontiers in Immunology, 2020, IF: 5.9, JCI: Q1, co-author

Comprehensive profiling of disease-relevant copy number aberrations for advanced clinical diagnostics of pediatric acute lymphoblastic leukemia. Kiss et al.; Modern Pathology, 2020, IF: 5.5, JCI: Q1, first author

Dissection of Subclonal Evolution by Temporal Mutation Profiling in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib. Gángó et al.; International Journal of Cancer, 2020, IF: 4.68, JCI: Q1, co-author

Ibrutinib resistance in chronic lymphocytic leukemia [HU]. Aczél et al.; Hematológia–Transzfuziológia, 2019, co-author

Cheekbone tumor — Richter syndrome [HU]. Csomor, Györke, Kiss, Mátrai; Hematológia–Transzfuziológia, 2019, co-author

Spatial Clonal Evolution Leading to Ibrutinib Resistance and Disease Progression In Chronic Lymphocytic Leukemia. Kiss et al.; Haematologica, 2019, IF: 7.9, JCI: Q1, first author

Dissection of Subclonal Evolution by Temporal Mutation Profiling in CLL Patients Treated with Ibrutinib [abstract]. Gángó A, Alpár D, Kiss R et al.; Clinical Lymphoma Myeloma & Leukemia, 2019, co-author

Screening for genomic copy number alterations in a family suffering from myelodysplastic syndrome using multiplex ligation-dependent probe amplification [HU]. Kotmayer et al.; Hematológia–Transzfuziológia, 2018, co-author

IGHV mutation analysis in chronic lymphocytic leukemia [HU]. Fésüs et al.; Hematológia–Transzfuziológia, 2018, co-author

Screening for genomic copy number alterations in chronic lymphocytic leukemia using multiplex ligation-dependent probe amplification [HU]. Kiss et al.; Hematológia–Transzfuziológia, 2018, corresponding author

Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms. Gángó et al.; Leukemia Research, 2018, IF: 1.62, JCI: Q2, co-author

Multiplex ligation-dependent probe amplification in oncohematological diagnostics and research [HU]. Kiss et al.; Orvosi Hetilap, 2018, IF: 0.9, JCI: Q3, first author

High-Throughput Copy Number Profiling by Digital Multiplex Ligation-Dependent Probe Amplification in Multiple Myeloma.Kosztolányi and Kiss et al.; Journal of Molecular Diagnostics, 2018, IF: 3.4, JCI: Q1, first author

Familial Acute Myeloid Leukemia and Myelodysplasia in Hungary. Király et al.; Pathology & Oncology Research, 2018, IF: 2.14, JCI: Q2, co-author

Dissection of Clonal Evolution By Temporal Mutation Profiling in Chronic Lymphocytic Leukemia [abstract]. Alpár D, Marosvári D, Kiss R et al.; Blood (ASH Annual Meeting Abstracts), 2017, co-author

Functional studies of chronic lymphocytic leukemia B cells expressing β2-integrin type complement receptors CR3 and CR4.Uzonyi et al.; Immunology Letters, 2017, IF: 2.61, JCI: Q2, co-author

Novelties and experiences in the tyrosine kinase inhibitor treatment of chronic myeloid leukemia. Gaál-Weisinger et al.; Magyar Onkológia, 2017, IF: 0.51, JCI: Q4, co-author

Current issues in molecular monitoring of chronic myeloid leukemia [HU]. Kiss et al.; Magyar Onkológia, 2017, IF: 0.51, JCI: Q4, first author

Significance of deep molecular response in chronic myeloid leukemia — Report on Hungarian standardization program in BCR-ABL1 monitoring [HU]. Andrikovics et al.; Hematológia–Transzfuziológia, 2017, co-author